食品伙伴网讯据美囼a href='//www.sqrdapp.com/news/tag_1647.html' class='zdbq' title='食品安全相关食品资讯' target='_blank'>食品安全新闻网消息,近日美国食品和药?a href='//www.sqrdapp.com/news/tag_4604.html' class='zdbq' title='管理相关食品资讯' target='_blank'>管理局'a href='//www.sqrdapp.com/news/tag_12.html' class='zdbq' title='FDA相关食品资讯' target='_blank'>FDA)就兽药替米考星(Tilmicosin)残留问题对弗吉尼亚州一宵a href='//www.sqrdapp.com/news/tag_1337.html' class='zdbq' title='牛肉相关食品资讯' target='_blank'>牛肉企业发布警告信、/p>
美国FDA称,该企业屠宰用肉牛体内兽药替米考星残留超标,其中肝脏组?9.994ppm,肌肉组?.914ppm,为FDA规定的肝脏组?.2ppm,肌肉组?.1ppm的标?6-30倍、/p>
美FDA检查发现,该企业还存在在购买兽药时未确认、使用处方药物的时候未经资质兽医同意等问题、/p>
部分原文报道如下9/p>
Tilmicosin is a veterinary antibiotic sold around the world under numerous brand names. It's used to treat cattle and sheep, respectively, for bovine and ovine respiratory diseases.
The U.S. Food and Drug Administration (FDA has established a safe (or tolerance level of 0.1 parts per million (ppm for residues of the drug in muscle tissue and 1.2 ppm in liver tissues.